88.5 F
San Fernando
Monday, Sep 25, 2023

Atara Prices Secondary Offering to Raise $128 Million

Atara Biotherapeutics Inc. has priced its secondary stock offering to raise nearly $128 million, the company announced late Wednesday. Atara is headquartered in South San Francisco but its research and development operation is in Westlake Village. The company researches treatments in T-cell immunotherapy. The secondary offering involves 7 million shares at $18.25 a share. It is expected to close on Jan. 8. Atara has granted the underwriters a 30-day option to sell an extra 1 million shares. J.P. Morgan and Cowen Group are joint book-running managers for the proposed offering. William Blair & Co. and Canaccord Genuity Inc. are co-managers. Shares of Atara (ATRA) closed Thursday down $1.25 or 6.5 percent to $18 on the Nasdaq.

Joel Russel
Joel Russel
Joel Russell joined the Los Angeles Business Journal in 2006 as a reporter. He transferred to sister publication San Fernando Valley Business Journal in 2012 as managing editor. Since he assumed the position of editor in 2015, the Business Journal has been recognized four times as the best small-circulation tabloid business publication in the country by the Alliance of Area Business Publishers. Previously, he worked as senior editor at Hispanic Business magazine and editor of Business Mexico.

Featured Articles

Related Articles